---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-22-025652"
form_type: "8-K"
ticker: "AXGN"
cik: "0000805928"
company_name: "Axogen, Inc."
filed_at: "2022-07-11T23:59:59+00:00"
generated_at: "2026-06-24T17:52:17.779408+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Axogen appoints William Burke to Board of Directors, effective July 11, 2022

## Summary
- William Burke, former EVP & CFO of Haemonetics, appointed as director effective July 11, 2022.
- Burke will chair the Audit Committee; board committees were reconstituted.
- Burke brings 25+ years of finance leadership from Medtronic, Covidien, and Haemonetics.
- Compensation includes $10,000 quarterly retainer, $5,000 as Audit Committee chair, plus equity grants.

## SEC filing metadata
- accession: 0001140361-22-025652
- form_type: 8-K
- ticker: AXGN
- cik: 0000805928
- company_name: Axogen, Inc.
- filed_at: 2022-07-11T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/805928/000114036122025652/0001140361-22-025652-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/805928/000114036122025652/brhc10039541_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-22-025652
- JSON: https://secwatch.observer/filing/0001140361-22-025652.json
- Plain text: https://secwatch.observer/filing/0001140361-22-025652.txt

## Key facts
- Executive change
  William Burke was appointed as Director at Axogen, Inc..
  - Action: appointed
  - Role: Director
  source text: On July 8, 2022, the board of directors (the “Board”) of Axogen, Inc. (the “Company”) appointed William Burke as a new director to fill the vacant directorship on the Board, effective July 11, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/805928/000114036122025652/0001140361-22-025652-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.